These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 16467545)

  • 1. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.
    Chambers CD; Hernandez-Diaz S; Van Marter LJ; Werler MM; Louik C; Jones KL; Mitchell AA
    N Engl J Med; 2006 Feb; 354(6):579-87. PubMed ID: 16467545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn.
    Huybrechts KF; Bateman BT; Palmsten K; Desai RJ; Patorno E; Gopalakrishnan C; Levin R; Mogun H; Hernandez-Diaz S
    JAMA; 2015 Jun; 313(21):2142-51. PubMed ID: 26034955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective Serotonin Reuptake Inhibitors and Persistent Pulmonary Hypertension of the Newborn: An Update Meta-Analysis.
    Ng QX; Venkatanarayanan N; Ho CYX; Sim WS; Lim DY; Yeo WS
    J Womens Health (Larchmt); 2019 Mar; 28(3):331-338. PubMed ID: 30407100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn.
    Andrade SE; McPhillips H; Loren D; Raebel MA; Lane K; Livingston J; Boudreau DM; Smith DH; Davis RL; Willy ME; Platt R
    Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):246-52. PubMed ID: 19148882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn.
    Bérard A; Sheehy O; Zhao JP; Vinet É; Bernatsky S; Abrahamowicz M
    Br J Clin Pharmacol; 2017 May; 83(5):1126-1133. PubMed ID: 27874994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.
    Masarwa R; Bar-Oz B; Gorelik E; Reif S; Perlman A; Matok I
    Am J Obstet Gynecol; 2019 Jan; 220(1):57.e1-57.e13. PubMed ID: 30170040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries.
    Kieler H; Artama M; Engeland A; Ericsson O; Furu K; Gissler M; Nielsen RB; Nørgaard M; Stephansson O; Valdimarsdottir U; Zoega H; Haglund B
    BMJ; 2012 Jan; 344():d8012. PubMed ID: 22240235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent pulmonary hypertension of the newborn and selective serotonin reuptake inhibitors: lessons from clinical and translational studies.
    Occhiogrosso M; Omran SS; Altemus M
    Am J Psychiatry; 2012 Feb; 169(2):134-40. PubMed ID: 22420034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SSRI antidepressants and persistent pulmonary hypertension in newborns.
    Prescrire Int; 2008 Aug; 17(96):156. PubMed ID: 19492488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent pulmonary hypertension of the newborn is associated with mode of delivery and not with maternal use of selective serotonin reuptake inhibitors.
    Wilson KL; Zelig CM; Harvey JP; Cunningham BS; Dolinsky BM; Napolitano PG
    Am J Perinatol; 2011 Jan; 28(1):19-24. PubMed ID: 20607643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal use of selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.
    Alwan S; Bandoli G; Chambers CD
    Clin Pharmacol Ther; 2016 Jul; 100(1):34-41. PubMed ID: 27060574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depressing observations on the use of selective serotonin-reuptake inhibitors during pregnancy.
    Mills JL
    N Engl J Med; 2006 Feb; 354(6):636-8. PubMed ID: 16467553
    [No Abstract]   [Full Text] [Related]  

  • 13. Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn.
    Källén B; Olausson PO
    Pharmacoepidemiol Drug Saf; 2008 Aug; 17(8):801-6. PubMed ID: 18314924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further findings linking SSRIs during pregnancy and persistent pulmonary hypertension of the newborn: clinical implications.
    Galbally M; Gentile S; Lewis AJ
    CNS Drugs; 2012 Oct; 26(10):813-22. PubMed ID: 22950489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse effects in neonates exposed to SSRIs and SNRI in late gestation--Motherisk Update 2008.
    Koren G; Boucher N
    Can J Clin Pharmacol; 2009; 16(1):e66-7. PubMed ID: 19164848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis.
    Grigoriadis S; Vonderporten EH; Mamisashvili L; Tomlinson G; Dennis CL; Koren G; Steiner M; Mousmanis P; Cheung A; Ross LE
    BMJ; 2014 Jan; 348():f6932. PubMed ID: 24429387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
    Brown AS; Gyllenberg D; Malm H; McKeague IW; Hinkka-Yli-Salomäki S; Artama M; Gissler M; Cheslack-Postava K; Weissman MM; Gingrich JA; Sourander A
    JAMA Psychiatry; 2016 Nov; 73(11):1163-1170. PubMed ID: 27732704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant use in pregnancy and the risk of cardiac defects.
    Huybrechts KF; Palmsten K; Avorn J; Cohen LS; Holmes LB; Franklin JM; Mogun H; Levin R; Kowal M; Setoguchi S; Hernández-Díaz S
    N Engl J Med; 2014 Jun; 370(25):2397-407. PubMed ID: 24941178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.
    Colvin L; Slack-Smith L; Stanley FJ; Bower C
    CNS Drugs; 2012 Jul; 26(7):e1-14. PubMed ID: 22712699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.